Identification of PD-1 ligands: PD-L1 and PD-L2 on macrophages in lung cancer milieu by flow cytometry

BACKGROUND: The efficacy of immune checkpoint inhibitors (ICIs) remains unexpected and in some patients the resistance to anti-programmed death-1 (anti-PD-1) and anti-programmed death ligand 1 (anti-PD-L1) agents is observed. One of possible explanation may be PD-L2 activity. PD-1 ligands: PD-L1 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwiecień, Iwona, Rutkowska, Elżbieta, Polubiec-Kownacka, Małgorzata, Raniszewska, Agata, Rzepecki, Piotr, Domagała-Kulawik, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107752/
https://www.ncbi.nlm.nih.gov/pubmed/34012784
http://dx.doi.org/10.21037/tlcr-20-1103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107752/
https://www.ncbi.nlm.nih.gov/pubmed/34012784
http://dx.doi.org/10.21037/tlcr-20-1103

Ejemplares similares